We are live on ! Find out more
GIM

Generali Investments Management Portfolio holdings

AUM $460M
1-Year Est. Return 29.43%
This Fund
S&P 500
This Quarter Est. Return
+11.29%
1 Year Est. Return
+29.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
+$37.6M
Cap. Flow
-$362K
Cap. Flow %
-0.08%
Top 10 Hldgs %
51.04%
Holding
183
New
22
Increased
64
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$15.2M
2
NFLX icon
Netflix
NFLX
+$4.13M
3
MSFT icon
Microsoft
MSFT
+$2.96M
4
PANW icon
Palo Alto Networks
PANW
+$2.89M
5
HIMS icon
Hims & Hers Health
HIMS
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 38.33%
2 Healthcare 16.11%
3 Communication Services 15.14%
4 Consumer Discretionary 13.51%
5 Financials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
76
3M
MMM
$94.4B
$1.09M 0.23%
7,002
FTNT icon
77
Fortinet
FTNT
$119B
$1.08M 0.23%
12,829
CRM icon
78
Salesforce
CRM
$161B
$1.07M 0.22%
4,514
-8,601
-66% -$2.17M
CME icon
79
CME Group
CME
$93.8B
$1.06M 0.22%
3,938
PM icon
80
Philip Morris
PM
$291B
$1.01M 0.21%
6,236
-457
-7% -$76.9K
WMT icon
81
Walmart Inc
WMT
$895B
$1.01M 0.21%
9,811
-13,184
-57% -$1.31M
GEHC icon
82
GE HealthCare
GEHC
$32.8B
$1M 0.21%
13,363
-4,215
-24% -$314K
HCA icon
83
HCA Healthcare
HCA
$89.1B
$992K 0.21%
2,328
+921
+65% +$357K
ECL icon
84
Ecolab
ECL
$79.6B
$977K 0.2%
3,568
+43
+1% +$11.7K
PEP icon
85
PepsiCo
PEP
$188B
$954K 0.2%
6,791
-5,566
-45% -$795K
CVS icon
86
CVS Health
CVS
$120B
$935K 0.2%
12,404
+1,550
+14% +$106K
COP icon
87
ConocoPhillips
COP
$151B
$929K 0.19%
9,823
-1,887
-16% -$178K
NEE icon
88
NextEra Energy
NEE
$179B
$926K 0.19%
12,262
+4,276
+54% +$312K
SPGI icon
89
S&P Global
SPGI
$120B
$790K 0.16%
1,624
+353
+28% +$189K
MO icon
90
Altria Group
MO
$108B
$776K 0.16%
11,745
+8,797
+298% +$557K
ZETA icon
91
Zeta Global
ZETA
$7.14B
$734K 0.15%
+36,941
New +$663K
EOG icon
92
EOG Resources
EOG
$75.1B
$729K 0.15%
6,498
-8,101
-55% -$966K
BMY icon
93
Bristol-Myers Squibb
BMY
$130B
$728K 0.15%
16,143
-2,154
-12% -$101K
VRTX icon
94
Vertex Pharmaceuticals
VRTX
$135B
$704K 0.15%
+1,797
New +$751K
TYL icon
95
Tyler Technologies
TYL
$13.2B
$702K 0.15%
+1,342
New +$753K
NBIX icon
96
Neurocrine Biosciences
NBIX
$16.5B
$696K 0.15%
4,958
+2,415
+95% +$327K
APH icon
97
Amphenol
APH
$207B
$696K 0.15%
5,623
+1,428
+34% +$157K
TWLO icon
98
Twilio
TWLO
$39.2B
$682K 0.14%
6,813
+2,372
+53% +$267K
REGN icon
99
Regeneron Pharmaceuticals
REGN
$83.1B
$676K 0.14%
+1,202
New +$680K
BKNG icon
100
Booking.com
BKNG
$161B
$670K 0.14%
3,100
+1,250
+68% +$279K

Similar funds

Generali Investments Management's Q3 2025 Portfolio in Review

As of Q3 2025, Generali Investments Management held 183 positions worth $479M, up 8.5% from $442M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Generali Investments Management's Q3 2025 filing shows 22 new, 64 increased, 64 reduced and 9 closed positions. Its largest new stake was BeOne Medicines Ltd: 8,000 shares worth $211K. The largest sale was Applied Materials, an estimated $7.68M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Communication Services.

  • Generali Investments Management's largest Q3 2025 buy was BeOne Medicines Ltd: 8,000 shares worth $211K.
  • Generali Investments Management added most to Tesla in Q3 2025, an estimated $15.2M increase.
  • Generali Investments Management's biggest Q3 2025 reduction was Applied Materials, cutting an estimated $7.68M.
  • Generali Investments Management fully exited State Street Communication Services Select Sector SPDR ETF in Q3 2025, selling an estimated $5.78M.
  • Generali Investments Management's ten largest holdings make up 51% of its $479M portfolio in Q3 2025.
  • Generali Investments Management opened 22 new positions and closed 9 in Q3 2025.
  • Generali Investments Management's portfolio value rose 8.5% quarter-over-quarter to $479M.

Based on Generali Investments Management's 13F filing for Q3 2025, filed 12 Nov 2025.